<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="Eric S. Orman, MD, MSCR, Division of Gastroenterology and Hepatology," exact="Indiana University" post="School of Medicine, 702 Rotary Cir, Ste 225, Indianapolis,"/>
 <result pre="Orman, MD, MSCR, Division of Gastroenterology and Hepatology, Indiana University" exact="School of Medicine," post="702 Rotary Cir, Ste 225, Indianapolis, IN 46202 (esorman@iu.edu)."/>
 <result pre="with NuSirt, Abbvie, Eli Lilly and Co, Afimmune (DS Biopharma)," exact="Allergan" post="(Tobira), Madrigal, Shire, Axovant, Coherus, Pronova (BASF), and Genentech;"/>
 <result pre="reported. Funding/Support: This study was supported in part by the" exact="Indiana Clinical and Translational Sciences Institute," post="which is funded in part by Clinical and Translational"/>
 <result pre="part by Clinical and Translational Sciences Award KL2TR001106 from the" exact="National Center for Advancing Translational Sciences," post="National Institutes of Health. This study was also supported"/>
 <result pre="Award KL2TR001106 from the National Center for Advancing Translational Sciences," exact="National Institutes of Health." post="This study was also supported in part by grant"/>
 <result pre="was also supported in part by grant K23DK109202 from the" exact="National Institute of Diabetes and Digestive and Kidney Diseases," post="National Institutes of Health. Role of the Funder/Sponsor: The"/>
 <result pre="the National Institute of Diabetes and Digestive and Kidney Diseases," exact="National Institutes of Health." post="Role of the Funder/Sponsor: The funders had no role"/>
 <result pre="and does not necessarily represent the official views of the" exact="National Institutes of Health." post="epub: 2019-6-6collection: 2019-6pmc-release: 2019-6-626e196412received: 2019-3-2accepted: 2019-5-12(C) , This is"/>
 <result pre="needed to identify the reasons for decreasing mortality rates. Funding" exact="Indiana Clinical and Translational Sciences Institute" post="National Center for Advancing Translational Sciences National Institutes of"/>
 <result pre="decreasing mortality rates. Funding Indiana Clinical and Translational Sciences Institute" exact="National Center for Advancing Translational Sciences" post="National Institutes of Health National Institute of Diabetes and"/>
 <result pre="and Translational Sciences Institute National Center for Advancing Translational Sciences" exact="National Institutes of Health" post="National Institute of Diabetes and Digestive and Kidney Diseases"/>
 <result pre="National Center for Advancing Translational Sciences National Institutes of Health" exact="National Institute of Diabetes and Digestive and Kidney Diseases" post="National Institutes of Health Introduction Cirrhosis is the end"/>
 <result pre="Health National Institute of Diabetes and Digestive and Kidney Diseases" exact="National Institutes of Health" post="Introduction Cirrhosis is the end point of a variety"/>
 <result pre="outcomes. Methods Study Design This study was approved by the" exact="Indiana University" post="institutional review board. Informed consent was waived because this"/>
 <result pre="are needed to continue to improve outcomes. References References 1collab:" exact="Centers for Disease Control and Prevention," post="National Center for Health Statistics Underlying cause of death"/>
 <result pre="outcomes. References References 1collab: Centers for Disease Control and Prevention," exact="National Center for Health Statistics" post="Underlying cause of death 1999-2017 on CDC WONDER online"/>
 <result pre="and management of hepatocellular carcinoma: 2018 practice guidance by the" exact="American Association for the Study of Liver Diseases." post="Hepatology. 2018;68(2):723-750. doi:10.1002/hep.2991329624699 29Garcia-TsaoG, AbraldesJG, BerzigottiA, BoschJPortal hypertensive bleeding"/>
 <result pre="risk stratification, diagnosis, and management: 2016 practice guidance by the" exact="American Association for the Study of Liver Diseases." post="Hepatology. 2017;65(1):310-335. doi:10.1002/hep.2890627786365 30GoldbergD, DitahIC, SaeianK, et al.Changes in"/>
 <result pre="waitlist removal due to clinical deterioration. Transplantation. 2017;101(10):2368-2374. doi:10.1097/TP.000000000000185128858174 32collab:" exact="Centers for Disease Control and Prevention" post="Historical reported cases and estimates of viral hepatitis. https://www.cdc.gov/hepatitis/statistics/incidencearchive.htm."/>
</results>
